Research Field Drug discovery

DONs Potential Unfolds

| Jonathan James

How DNA origami nanostructures could find their way into the treatment of acute kidney injury.

Research Field Cell & molecular biology

H(eye) - or Low?

| Phoebe Harkin

Two chemical components; opposite effects. How medical marijuana impacts glaucoma for better – and for worse.

Disease Area Cancer

The Relentless Cancer Researcher

| Jonathan James

Sitting Down With… Ingun Holen, Professor of Bone Oncology at the University of Sheffield Medical School, Sheffield, UK.

Research Field Neuroscience

Building up to a breakthrough

| Jonathan James

We sat down with David Eidelberg shortly after the publication of his group’s most recent paper in Science Translational Medicine.

Disease Area Pain & critical care

Putting Your Back into It

| Jonathan James

Progress in tissue engineering may offer hope to patients suffering from debilitating intervertebral disc degeneration.

Outside the Lab Public health

Medical Robotics Are the Future

| Jeremy Russell

As healthcare systems across the globe feel the strain of an increasing (and aging) population, we need someone – or rather something – to lend a help

Disease Area Neurological

A Neural Precedent

| Jonathan James

Interneuron activity suggests that there’s more to the story of seizure onset

Disease Area Neuroscience

Brain Network Manipulation

| Jonathan James

Cutting-edge imaging, predictive modeling and gene therapy combine for a new direction in neurodegenerative disease research

Disease Area Infectious diseases

Andes Antibody Advancement

| Jonathan James

A antibody discovery platform emerges to tackle the growing problem of Andes Hantavirus cardiopulmonary syndrome (AHCPS)

Disease Area Cancer

More than METs the Eye

| Jonathan James

The role of different types of MET mutation in lung cancer could demand a rethink of treatments.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register